Independent Anti-Angiogenic Capacities of Coagulation Factors X and Xa-Reference-Cited by-同舟云学术

Independent Anti-Angiogenic Capacities of Coagulation Factors X and Xa

Published:2014-07-29 Issue:11 Volume:229 Page:1673-1680
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol

Author:

Lange Soledad¹,Gonzalez Ibeth¹,Pinto Mauricio P.¹,Arce Maximiliano¹,Valenzuela Rodrigo¹,Aranda Evelyn¹,Elliot Matias²³,Alvarez Marjorie²³,Henriquez Soledad¹,Velasquez Ethel V.¹,Orge Felipe¹,Oliva Barbara¹,Gonzalez Pamela¹,Villalon Manuel¹,Cautivo Kelly M.⁴,Kalergis Alexis M.⁴⁵⁶,Pereira Karla⁷,Mendoza Camila⁷,Saez Claudia⁷,Kato Sumie⁸,Cuello Mauricio A.⁸,Parborell Fernanda⁹,Irusta Griselda⁹,Palma Veronica²³,Allende Miguel L.²³,Owen Gareth I.¹⁶¹⁰¹¹

Affiliation:

1. Departamento de Fisiología, Facultad de Ciencias Biológicas; Pontificia Universidad Católica de Chile; Santiago Chile

2. Departamento de Biología, Facultad de Ciencias; Universidad de Chile; Santiago Chile

3. FONDAP Center for Genome Regulation, Facultad de Ciencias; Universidad de Chile; Santiago Chile

4. Millennium Institute on Immunology and Immunotherapy, Departamento de Genética Molecular y Microbiología; Pontificia Universidad Católica de Chile; Santiago Chile

5. Departamento de Reumatología, Facultad de Medicina; Pontificia Universidad Católica de Chile; Santiago Chile

6. Biomedical Research Consortium Chile (BMRC); Santiago Chile

7. Departamento de Hematología-Oncología, Facultad de Medicina; Pontificia Universidad Católica de Chile; Santiago Chile

8. Departamento de Obstetricia y Ginecología, Facultad de Medicina; Pontificia Universidad Católica de Chile; Santiago Chile

9. Instituto de Biología y Medicina Experimental (IByME-CONICET); Buenos Aires Argentina

10. Centro UC Investigación en Oncología; Pontificia Universidad Católica de Chile; Santiago Chile

11. FONDAP Advanced Center forChronicDiseases (ACCDis); Pontificia Universidad Católica de Chile; Santiago Chile

Funder

BMRC

FONDAP

FONDECYT

Anillo

MIFAB

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference51 articles.

1. Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin;Al-Ani;J Pharmacol Exp Ther,2002

2. A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA. hy926 endothelial cell line;Aranda;Biol Res,2009

3. Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1;Bae;J Biol Chem,2010

4. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2;Bergum;J Biol Chem,2001

5. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2;Bohm;Biochem J,1996

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. F10 Gene Expression and Ethnic Disparities Present in Papillary Thyroid Carcinoma;Journal of Personalized Medicine;2024-05-15

2. Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review;Frontiers in Pharmacology;2023-09-29

3. Identification of VEGFR2 as the Histatin-1 receptor in endothelial cells;Biochemical Pharmacology;2022-07

4. Impact of the Potential Antitumor Agent 2-(4-Hydroxyphenyl) Amino-1,4-Naphthoquinone (Q7) on Vasomotion Is Mediated by the Vascular Endothelium, But Not Vascular Smooth Muscle Cell Metabolism;Journal of Cardiovascular Pharmacology;2021-02

5. Deciphering the Role of the Coagulation Cascade and Autophagy in Cancer-Related Thrombosis and Metastasis;Frontiers in Oncology;2020-12-07